4.5 Article

A novel recurrent mutation in ATP1A3 causes CAPOS syndrome

Journal

ORPHANET JOURNAL OF RARE DISEASES
Volume 9, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1750-1172-9-15

Keywords

CAPOS syndrome; Cerebellar ataxia; Optic atrophy; Sensorineural hearing loss; ATP1A3

Funding

  1. Genome Canada
  2. Genome British Columbia through the FORGE Canada Consortium
  3. British Columbia Clinical Genomics Network
  4. Michael Smith Foundation for Health Research
  5. Rare Disease Foundation
  6. Omics2TreatID
  7. Canadian Institutes of Health Research

Ask authors/readers for more resources

Background: We undertook genetic analysis of three affected families to identify the cause of dominantly-inherited CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss) syndrome. Methods: We used whole-exome sequencing to analyze two families affected with CAPOS syndrome, including the original family reported in 1996, and Sanger sequencing to assess familial segregation of rare variants identified in the probands and in a third, apparently unrelated family with CAPOS syndrome. Results: We found an identical heterozygous missense mutation, c.2452G>A (p.(Glu818Lys)), in the Na+/K+ ATPase alpha(3) (ATP1A3) gene in the proband and his affected sister and mother, but not in either unaffected maternal grandparent, in the first family. The same mutation was also identified in the proband and three other affected members of the second family and in all three affected members of the third family. This mutation was not found in more than 3600 chromosomes from unaffected individuals. Conclusion: Other mutations in ATP1A3 have previously been demonstrated to cause rapid-onset dystonia-parkinsonism (also called dystonia- 12) or alternating hemiplegia of childhood. This study shows that an allelic mutation in ATP1A3 produces CAPOS syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available